Who is sponsoring NCT03615430?

NCT03615430 is sponsored by Feng Xia.

What drugs are being tested in NCT03615430?

Interventions in NCT03615430: serratus plane block with local anesthetic, serratus plane block with saline.

What condition does NCT03615430 study?

NCT03615430 studies Serratus Plane Block, Chronic Pain, Breast Cancer.

Is NCT03615430 still recruiting?

NCT03615430 is currently completed. Last updated 8 April 2020.

Last reviewed 2020-04-08 · How we verify

NCT03615430

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Serratus Plane Block in Preventing Postoperative Pain of Mastectomy

Completed NA Last updated 8 April 2020

What this trial tests

NA trial testing serratus plane block with local anesthetic in Serratus Plane Block in 50 participants. Completed in 1 December 2019.

Timeline

1 August 2018

Primary endpoint
1 December 2019

1 December 2019

Quick facts

Lead sponsor	Feng Xia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	50
Start date	1 August 2018
Primary completion	1 December 2019
Estimated completion	1 December 2019
Sites	1 location across China

Drugs / interventions tested

serratus plane block with local anesthetic
serratus plane block with saline

Conditions studied

Serratus Plane Block — all drugs for Serratus Plane Block →
Chronic Pain — all drugs for Chronic Pain →
Breast Cancer — all drugs for Breast Cancer →

Sponsor

Feng Xia — full company profile →

Who can join

Adults 18 to 85, female only, with Serratus Plane Block or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A prospective, double-blinded randomized controlled, 1-year follow-up study was designed to compare the analgesic effect of serratus plane block (SPB) after breast cancer surgery. Women undergoing radical mastectomy were dIvided into Control group and SPB group. The postoperative acute pain was evaluated by numerical rating scale (NRS) and the effect of preventing chronic pain was assessed at 3, 6, 12 months after surgery by NRS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Feng Xia trials

Trials by the same sponsor.

NCT03333902 — The Comparison Of Nerve Blocks In Cesarean Delivery · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03615430 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Feng Xia
Last refreshed: 8 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03615430.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing